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may also aid in distinguishing BCC subtypes as relevant for 
therapeutic choices. Br J Dermatol 2012; 167: 856–64.
Expression of microRNAs in basal cell 
carcinoma
Sand et al. identified 16 significantly upregulated (hsa-miR-17, 
miR-18a, hsa-miR-18b, hsa-miR-19b, hsa-miR-19b-1*, hsa-
miR-93, hsa-miR-106b, hsa-miR-125a-5p, hsa-miR-130a, 
hsa-miR-181c, hsa-miR-181c*, hsa-miR-181d, hsa-miR-182, 
hsa-miR-455-3p, hsa-miR-455-5p and hsa-miR-542-5p) 
and 10 significantly downregulated (hsa-miR-29c, hsa-
miR-29c*, hsa-miR-139-5p, hsa-miR-140-3p, hsa-miR-145, 
hsa-miR-378, hsa-miR-572, hsa-miR-638, hsa-miR-2861 and 
hsa-miR-3196) microRNAs (miRNAs) in basal cell carcinoma 
(BCC) compared with nonlesional skin. Data mining revealed 
connections to many tumour-promoting pathways, such as 
the Hedgehog and the mitogen-activated protein kinase/extra-
cellular signal-regulated kinase signalling cascades. This is the 
first study to identify miRNA candidates that may play a role 
in the molecular pathogenesis of BCC. Br J Dermatol 2012; 
167: 847–855.
Second primary melanomas in paediatric 
and adult populations
In a retrospective analysis, a total of 208,289 patients were 
diagnosed with invasive melanoma in the Surveillance 
Epidemiology and End Results database from 1973 to 
2008 with subsequent primary melanomas diagnosed in 
3.3% (6888). The incidence of second primary melanomas 
increased with increasing age at diagnosis of the patient’s 
first melanoma. The relative risk of developing a subse-
quent melanoma was nearly double for patients diagnosed 
with their first melanoma at the age of 19 years and youn-
ger compared with patients aged greater than 19 years. 
The heightened relative risk of second primary melanomas 
in the paediatric population calls for careful long-term 
scrutiny. Br J Dermatol 2012; 167: 882–888.
Association of VDR polymorphisms  
and vitiligo risk
This Chinese hospital-based study of 749 patients with vit-
iligo and 763 matched controls investigated four vitamin 
D receptor (VDR) polymorphisms (FokI, BsmI, ApaI and 
TaqI) and 25-hydroxyvitamin D [25(OH)D] levels. A sig-
nificantly decreased risk of developing vitiligo was found 
to be associated with the BsmI-B, ApaI-A and TaqI-t alleles. 
According to the genotype distribution, 25(OH)D concen-
trations were significantly higher in patients carrying the 
FokI ff or ApaI AA genotypes compared with those car-
rying the FF or aa genotypes. Logistic regression analysis 
showed a dose–response relationship between decreased 
risk of vitiligo and increased 25(OH)D levels in ApaI-A 
variant genotype carriers. It is concluded that VDR gene 
polymorphisms may affect 25(OH)D levels and the risk for 
the development of vitiligo in the Chinese population. Br J 
Dermatol 2012; 167: 815–821.
Imaging of BCC by HD-OCT
Skin lesions of 21 patients with a histologically proven 
basal cell carcinoma (BCC) were imaged by high-definition 
optical coherence tomography (HD-OCT) just before exci-
sion. Features defined for reflectance confocal microscopy 
(RCM) and conventional optical coherence tomography 
(OCT) were compared with histology. Features of BCC 
detected by both techniques were observed by HD-OCT, 
suggesting that HD-OCT fills the imaging gap between 
RCM and conventional OCT. It is concluded that HD-OCT 
may not only facilitate the in vivo diagnosis of BCC but 
